1
|
Cabral AMTDPV, Fernandes ACG, Joaquim NAM, Veiga F, Sofio SPC, Paiva I, Esteso MA, Rodrigo MM, Valente AJM, Ribeiro ACF. Complexation of 5-Fluorouracil with β-Cyclodextrin and Sodium Dodecyl Sulfate: A Useful Tool for Encapsulating and Removing This Polluting Drug. TOXICS 2022; 10:toxics10060300. [PMID: 35736908 PMCID: PMC9228719 DOI: 10.3390/toxics10060300] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Revised: 05/25/2022] [Accepted: 05/27/2022] [Indexed: 02/04/2023]
Abstract
The formation of complexes of the drug 5-fluorouracil (5-FU) with β-cyclodextrin (β-CD) and sodium dodecyl sulphate (SDS) was studied through experimental measurements of the ternary mutual diffusion coefficients (D11, D22, D12, and D21) for the systems {5-FU (component 1) + β-CD (component 2) + water} and {5-FU (component 1) + SDS (component 2) + water} at 298.15 K and at concentrations up to 0.05 mol dm−3 by using the Taylor dispersion method, with the objective of removing this polluting drug from the residual systems in which it was present. The results found showed that a coupled diffusion of 5-FU occurred with both β-CD and SDS, as indicated by the nonzero values of the cross-diffusion coefficients, D12 and D21, as a consequence of the complex formation between 5-FU and the β-CD or SDS species. That is, 5-FU was solubilized (encapsulated) by both carriers, although to a greater extent with SDS (K = 20.0 (±0.5) mol−1 dm3) than with β-CD (K = 10.0 (±0.5) mol−1 dm3). Values of 0.107 and 0.190 were determined for the maximum fraction of 5-FU solubilized with β-CD and SDS (at concentrations above its CMC), respectively. This meant that SDS was more efficient at encapsulating and thus removing the 5-FU drug.
Collapse
Affiliation(s)
- Ana M. T. D. P. V. Cabral
- Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; (A.M.T.D.P.V.C.); (N.A.M.J.); (F.V.)
- Department of Chemistry, CQC, Institute of Molecular Sciences, University of Coimbra, 3004-535 Coimbra, Portugal; (A.C.G.F.); (S.P.C.S.); (A.J.M.V.)
| | - Ana C. G. Fernandes
- Department of Chemistry, CQC, Institute of Molecular Sciences, University of Coimbra, 3004-535 Coimbra, Portugal; (A.C.G.F.); (S.P.C.S.); (A.J.M.V.)
| | - Neuza A. M. Joaquim
- Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; (A.M.T.D.P.V.C.); (N.A.M.J.); (F.V.)
| | - Francisco Veiga
- Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; (A.M.T.D.P.V.C.); (N.A.M.J.); (F.V.)
| | - Sara P. C. Sofio
- Department of Chemistry, CQC, Institute of Molecular Sciences, University of Coimbra, 3004-535 Coimbra, Portugal; (A.C.G.F.); (S.P.C.S.); (A.J.M.V.)
| | - Isabel Paiva
- Centre of Geography and Spatial Planning, Department of Geography and Tourism, University of Coimbra, 3004-530 Coimbra, Portugal;
| | - Miguel A. Esteso
- Universidad Católica de Ávila, Calle los Canteros s/n, 05005 Ávila, Spain
- U.D. Química Física, Universidad de Alcalá, 28805 Alcalá de Henares, Spain;
- Correspondence: (M.A.E.); (A.C.F.R.)
| | - M. Melia Rodrigo
- U.D. Química Física, Universidad de Alcalá, 28805 Alcalá de Henares, Spain;
| | - Artur J. M. Valente
- Department of Chemistry, CQC, Institute of Molecular Sciences, University of Coimbra, 3004-535 Coimbra, Portugal; (A.C.G.F.); (S.P.C.S.); (A.J.M.V.)
| | - Ana C. F. Ribeiro
- Department of Chemistry, CQC, Institute of Molecular Sciences, University of Coimbra, 3004-535 Coimbra, Portugal; (A.C.G.F.); (S.P.C.S.); (A.J.M.V.)
- Correspondence: (M.A.E.); (A.C.F.R.)
| |
Collapse
|
2
|
Lakkakula JR, Krause RWM, Divakaran D, Barage S, Srivastava R. 5-Fu inclusion complex capped gold nanoparticles for breast cancer therapy. J Mol Liq 2021. [DOI: 10.1016/j.molliq.2021.117262] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
3
|
Ceci C, Graziani G, Faraoni I, Cacciotti I. Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers. NANOTECHNOLOGY 2020; 31:382001. [PMID: 32380485 DOI: 10.1088/1361-6528/ab912c] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Ellagic acid (EA) is a polyphenolic compound whose dietary consumption is mainly associated with the intake of red fruits, including pomegranates, strawberries, blackberries, blackcurrants, raspberries, grapes or dried fruits, like walnuts and almonds. A number of studies indicate that EA exerts health-beneficial effects against several chronic pathologies associated with oxidative damage, including different kinds of cancer, cardiovascular and neurodegenerative diseases. Furthermore, EA possesses wound-healing properties, antibacterial and antiviral effects, and acts as a systemic antioxidant. However, clinical applications of this polyphenol have been hampered and prevented by its poor water solubility (9.7 ± 3.2 μg ml-1 in water) and pharmacokinetic profile (limited absorption rate and plasma half-life <1 h after ingestion of pomegranate juice), properties due to the chemical nature of the organic heterotetracyclic compound. Little has been reported on efficient strategies to enhance EA poor oral bioavailability, including chemical structure modifications, encapsulation within nano-microspheres to be used as carriers, and molecular dispersion in polymer matrices. In this review we summarize the experimental approaches investigated so far in order to improve EA pharmacokinetics, supporting the hypothesis that enhancement in EA solubility is a feasible route for increasing its oral absorption.
Collapse
Affiliation(s)
- Claudia Ceci
- Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1 00133, Rome, Italy
| | | | | | | |
Collapse
|
4
|
Samrot AV, Burman U, Philip SA, N S, Chandrasekaran K. Synthesis of curcumin loaded polymeric nanoparticles from crab shell derived chitosan for drug delivery. INFORMATICS IN MEDICINE UNLOCKED 2018. [DOI: 10.1016/j.imu.2017.12.010] [Citation(s) in RCA: 59] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
|
5
|
Bachhav SS, Dighe VD, Kotak D, Devarajan PV. Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer’s patch uptake. Int J Pharm 2017; 532:612-622. [DOI: 10.1016/j.ijpharm.2017.09.040] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2017] [Revised: 08/28/2017] [Accepted: 09/16/2017] [Indexed: 12/25/2022]
|
6
|
Iglesias T, Dusinska M, El Yamani N, Irache JM, Azqueta A, López de Cerain A. In vitro evaluation of the genotoxicity of poly(anhydride) nanoparticles designed for oral drug delivery. Int J Pharm 2017; 523:418-426. [PMID: 28286081 DOI: 10.1016/j.ijpharm.2017.03.016] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2017] [Revised: 03/07/2017] [Accepted: 03/08/2017] [Indexed: 10/20/2022]
Abstract
In the last years, the development of nanomaterials has significantly increased due to the immense variety of potential applications in technological sectors, such as medicine, pharmacy and food safety. Focusing on the nanodevices for oral drug delivery, poly(anhydride) nanoparticles have received extensive attention due to their unique properties, such as their capability to develop intense adhesive interactions within the gut mucosa, their modifiable surface and their biodegradable and easy-to-produce profile. However, current knowledge of the possible adverse health effects as well as, toxicological information, is still exceedingly limited. Thus, we investigated the capacity of two poly(anhydride) nanoparticles, Gantrez® AN 119-NP (GN-NP) and Gantrez® AN 119 covered with mannosamine (GN-MA-NP), and their main bulk material (Gantrez® AN 119-Polymer), to induce DNA damage and thymidine kinase (TK+/-) mutations in L5178Y TK+/- mouse lymphoma cells after 24h of exposure. The results showed that GN-NP, GN-MA-NP and their polymer did not induce DNA strand breaks or oxidative damage at concentrations ranging from 7.4 to 600μg/mL. Besides, the mutagenic potential of these nanoparticles and their polymer revealed no significant or biologically relevant gene mutation induction at concentrations up to 600μg/mL under our experimental settings. Considering the non-genotoxic effects of GN-NP and GN-MA-NP, as well as their exceptional properties, these nanoparticles are promising nanocarriers for oral medical administrations.
Collapse
Affiliation(s)
- T Iglesias
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain
| | - M Dusinska
- Health Effects Laboratory, Department of Environmental Chemistry, Norwegian Institute for Air Research, Kjeller, Norway
| | - N El Yamani
- Health Effects Laboratory, Department of Environmental Chemistry, Norwegian Institute for Air Research, Kjeller, Norway
| | - J M Irache
- Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy and Nutrition, University of Navarra, Irunlarrea 1, 31008, Pamplona, Spain
| | - A Azqueta
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain.
| | - A López de Cerain
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain
| |
Collapse
|
7
|
Iglesias T, López de Cerain A, Irache JM, Martín-Arbella N, Wilcox M, Pearson J, Azqueta A. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery. Int J Pharm 2017; 517:67-79. [DOI: 10.1016/j.ijpharm.2016.11.059] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2016] [Revised: 11/23/2016] [Accepted: 11/27/2016] [Indexed: 01/20/2023]
|
8
|
Del Castillo-Santaella T, Maldonado-Valderrama J, Molina-Bolivar JA, Galisteo-Gonzalez F. Effect of cross-linker glutaraldehyde on gastric digestion of emulsified albumin. Colloids Surf B Biointerfaces 2016; 145:899-905. [PMID: 27341303 DOI: 10.1016/j.colsurfb.2016.06.014] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2016] [Revised: 04/22/2016] [Accepted: 06/08/2016] [Indexed: 11/18/2022]
Abstract
Human serum albumin (HSA) has been shown to be an ideal protein for nanoparticle preparation. These are usually prepared by using cross linker agents such as glutaraldehyde (GAD). Liquid lipid nanocapsules (LLN) constitute a new generation of nanoparticles more biocompatible and versatile for oral delivery of lipophylic drugs. The first barrier that an orally administered formulation must cross is the gastrointestinal tract. Hence, it is crucial to address the impact of gastrointestinal digestion on these structures in order to achieve an optimal formulation. This study evaluates the effect of gastric digestion on HSA emulsions structured with GAD as a model substrate for the preparation of LLN. This is done by SDS-PAGE, emulsion microstructure, and interfacial tension techniques. Our results demonstrate that the cross- linking procedure with GAD strongly inhibits pepsin digestion by formation of inter- and/or intramolecular covalent bonds between substrate amino acids. Emulsification of HSA also protects from gastric digestion probably by the orientation of the HSA molecule, which exposes the majority of pepsin cleaving sites preferably to the hydrophobic part of the oil-water interface. In this emulsified HSA, cross-linking with GAD at the interface promotes structural modifications on the HSA interfacial layer, restricting the access of pepsin to cleavage sites. We identify interfacial aspects underlying enzymatic hydrolysis of the protein. Assuring that HSA-GAD structures resist passage through the gastric compartment is crucial is important towards the rational design of oral delivery systems and the first step to get the complete digestion profile.
Collapse
|
9
|
Oral delivery of camptothecin using cyclodextrin/poly(anhydride) nanoparticles. Int J Pharm 2016; 506:116-28. [DOI: 10.1016/j.ijpharm.2016.04.045] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2016] [Revised: 04/15/2016] [Accepted: 04/16/2016] [Indexed: 11/17/2022]
|
10
|
Abstract
Nanotechnology is a multidisciplinary field that covers a vast and diverse array of devices derived from physics, biology, engineering, and chemistry. Applications of nanotechnology to medicine and physiology imply materials and devices designed to interact with the body at subcellular (i.e., molecular) scales with a high degree of specificity. There is considerable useful information about nanotechnology available and already in use. However, at present, it is very incomplete and scattered. We realized many doctors are unaware of nanotechnology used during surgery and its future prospects in patients. Though most medical products that use nanotechnology are still in the research and development stage, there are a few which are commercially available. Nanotechnology has grown by leaps and bounds over the last few years; applications of this technology in the field of medicine and surgery have been an important spin-off. Many biological structures are at nanometer scale used by surgeons in orthopedic, dental, and neurosurgeries. This article starts with the basics of the nanotechnology and how it is utilized through most medical products. This important article, which is felt to offer high educational value for the doctors, have been selected from an extensive search on the internet, and elaborately discussed. In this review, the scientific and technical aspects of nanotechnology are introduced, and some of its potential clinical applications are discussed.
Collapse
Affiliation(s)
- Sanjeev Singh
- Department of Anaesthesia and Intensive Care, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, West Africa ; NHIMS, Department of Cardiac Anaesthesia, Bangalore, India
| | - Arti Singh
- Department of Public health, KNUST Hospital, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, West Africa
| |
Collapse
|
11
|
Sustained release and enhanced bioavailability of injectable scutellarin-loaded bovine serum albumin nanoparticles. Int J Pharm 2014; 476:142-8. [PMID: 25269007 DOI: 10.1016/j.ijpharm.2014.09.038] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2014] [Revised: 09/08/2014] [Accepted: 09/26/2014] [Indexed: 11/23/2022]
Abstract
The aim of this study is to characterize the in-vitro physicochemical and in-vivo pharmacokinetic properties of the scutellarin-loaded bovine serum albumin nanoparticles (STA-BSA-NPs). STA existed as amorphous form in the nanoparticles. Reconstituted STA-BSA-NPs had an average particle size of 283.4 nm and a zeta potential of +17.95 mV. The in-vitro sustained release profile was well fitted with Weibull distribution model. In comparison to STA solution, STA-BSA-NPs exhibited a significantly higher plasma concentration from 20 min to 6 h after intravenous administration to rats. In addition, significantly higher AUC(0-inf) (2.8-fold), prolonged elimination half-life (4.2-fold) and lower clearance (2.7-fold) were achieved.
Collapse
|
12
|
Mei L, Zhang Z, Zhao L, Huang L, Yang XL, Tang J, Feng SS. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev 2013; 65:880-90. [PMID: 23220325 DOI: 10.1016/j.addr.2012.11.005] [Citation(s) in RCA: 248] [Impact Index Per Article: 22.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2012] [Revised: 10/28/2012] [Accepted: 11/07/2012] [Indexed: 01/01/2023]
Abstract
Oral chemotherapy is an important topic in the 21st century medicine, which may radically change the current regimen of chemotherapy and greatly improve the quality of life of the patients. Unfortunately, most anticancer drugs, especially those of high therapeutic efficacy such as paclitaxel and docetaxel, are not orally bioavailable due to the gastrointestinal (GI) drug barrier. The molecular basis of the GI barrier has been found mainly due to the multidrug efflux proteins, i.e. P-type glycoproteins (P-gp), which are rich in the epithelial cell membranes in the GI tract. Medical solution for oral chemotherapy is to apply P-gp inhibitors such as cyclosporine A, which, however, suppress the body's immune system either, thus causing medical complication. Pharmaceutical nanotechnology, which is to apply and further develop nanotechnology to solve the problems in drug delivery, may provide a better solution and thus change the way we make drug and the way we take drug. This review is focused on the problems encountered in oral chemotherapy and the pharmaceutical nanotechnology solutions such as prodrugs, nanoemulsions, dendrimers, micelles, liposomes, solid lipid nanoparticles and nanoparticles of biodegradable polymers. Proof-of-concept in vitro and in vivo results for oral delivery of anticancer drugs by the various nanocarriers, which can be found so far from the literature, are provided.
Collapse
|
13
|
Elizondo E, Veciana J, Ventosa N. Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids. Nanomedicine (Lond) 2012; 7:1391-408. [DOI: 10.2217/nnm.12.110] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
The structuring of synthetic and biological therapeutic actives as micro- and nano-particulate materials is a widely accepted formulation strategy to improve efficacy and reduce the toxicity of drugs. However, the development of efficient production platforms that enable the formulation of these nanomedicines at an industrial scale and with the quality requirements imposed by regulatory agencies remains a challenge. In this framework, compressed fluid-based methods are promising technologies for the controlled and reproducible preparation of uniform micro- and nano-particulate nanomedicines at a large scale. This review provides an overall but practical knowledge about what has been achieved so far in the field of compressed fluids applied to the preparation of solid micro- and nanoparticles and vesicles as drug delivery systems. In addition, recent examples of application of these technologies to the production of polymeric nanostructured microparticles highly loaded with gentamicin and to the preparation of uniform cholesterol-rich vesicular systems are explained.
Collapse
Affiliation(s)
- Elisa Elizondo
- Departament de Nanociència Molecular i Materials Orgànics, Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus de la UAB, 08193, Bellaterra, Barcelona, Spain
- CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 08193, Bellaterra, Barcelona, Spain
| | - Jaume Veciana
- Departament de Nanociència Molecular i Materials Orgànics, Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus de la UAB, 08193, Bellaterra, Barcelona, Spain
- CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 08193, Bellaterra, Barcelona, Spain
| | - Nora Ventosa
- Departament de Nanociència Molecular i Materials Orgànics, Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus de la UAB, 08193, Bellaterra, Barcelona, Spain
| |
Collapse
|
14
|
Fakruddin M, Hossain Z, Afroz H. Prospects and applications of nanobiotechnology: a medical perspective. J Nanobiotechnology 2012; 10:31. [PMID: 22817658 PMCID: PMC3422163 DOI: 10.1186/1477-3155-10-31] [Citation(s) in RCA: 132] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2012] [Accepted: 07/20/2012] [Indexed: 01/22/2023] Open
Abstract
BACKGROUND Nanobiotechnology is the application of nanotechnology in biological fields. Nanotechnology is a multidisciplinary field that currently recruits approach, technology and facility available in conventional as well as advanced avenues of engineering, physics, chemistry and biology. METHOD A comprehensive review of the literature on the principles, limitations, challenges, improvements and applications of nanotechnology in medical science was performed. RESULTS Nanobiotechnology has multitude of potentials for advancing medical science thereby improving health care practices around the world. Many novel nanoparticles and nanodevices are expected to be used, with an enormous positive impact on human health. While true clinical applications of nanotechnology are still practically inexistent, a significant number of promising medical projects are in an advanced experimental stage. Implementation of nanotechnology in medicine and physiology means that mechanisms and devices are so technically designed that they can interact with sub-cellular (i.e. molecular) levels of the body with a high degree of specificity. Thus therapeutic efficacy can be achieved to maximum with minimal side effects by means of the targeted cell or tissue-specific clinical intervention. CONCLUSION More detailed research and careful clinical trials are still required to introduce diverse components of nanobiotechnology in random clinical applications with success. Ethical and moral concerns also need to be addressed in parallel with the new developments.
Collapse
Affiliation(s)
- Md Fakruddin
- Institute of Food Science and Technology (IFST), Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh
| | - Zakir Hossain
- Institute of Food Science and Technology (IFST), Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh
| | - Hafsa Afroz
- Department of Microbiology, Primeasia University, Dhaka, Bangladesh
| |
Collapse
|
15
|
Martins RDC, Irache JM, Gamazo C. Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease. Expert Rev Vaccines 2012; 11:87-95. [PMID: 22149711 DOI: 10.1586/erv.11.172] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Ovine brucellosis is a very contagious zoonotic disease distributed worldwide and constitutes a very important zoosanitary and economic problem. The control of the disease includes animal vaccination and slaughter of infected flocks. However, the commercially available vaccine in most countries is based on the attenuated strain Brucella melitensis Rev 1, which presents important safety drawbacks. This review is focused on the most recent and promising acellular vaccine proposals.
Collapse
Affiliation(s)
- Raquel Da Costa Martins
- Department of Pharmaceutics and Pharmaceutical Technology, University of Navarra, C/Irunlarrea, 1 31008-Pamplona, Spain
| | | | | |
Collapse
|
16
|
Toxicity studies of poly(anhydride) nanoparticles as carriers for oral drug delivery. Pharm Res 2012; 29:2615-27. [PMID: 22638871 DOI: 10.1007/s11095-012-0791-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2012] [Accepted: 05/15/2012] [Indexed: 10/28/2022]
Abstract
PURPOSE To evaluate the acute and subacute toxicity of poly(anhydride) nanoparticles as carriers for oral drug/antigen delivery. METHODS Three types of poly(anhydride) nanoparticles were assayed: conventional (NP), nanoparticles containing 2-hydroxypropyl-β-cyclodextrin (NP-HPCD) and nanoparticles coated with poly(ethylene glycol) 6000 (PEG-NP). Nanoparticles were prepared by a desolvation method and characterized in terms of size, zeta potential and morphology. For in vivo oral studies, acute and sub-acute toxicity studies were performed in rats in accordance to the OECD 425 and 407 guidelines respectively. Finally, biodistribution studies were carried out after radiolabelling nanoparticles with (99m)technetium. RESULTS Nanoparticle formulations displayed a homogeneous size of about 180 nm and a negative zeta potential. The LD(50) for all the nanoparticles tested was established to be higher than 2000 mg/kg bw. In the sub-chronic oral toxicity studies at two different doses (30 and 300 mg/kg bw), no evident signs of toxicity were found. Lastly, biodistribution studies demonstrated that these carriers remained in the gut with no evidences of particle translocation or distribution to other organs. CONCLUSIONS Poly(anhydride) nanoparticles (either conventional or modified with HPCD or PEG6000) showed no toxic effects, indicating that these carriers might be a safe strategy for oral delivery of therapeutics.
Collapse
|
17
|
Abstract
The oral route is preferred by patients for drug administration due to its convenience, resulting in improved compliance. Unfortunately, for a number of drugs (e.g., anticancer drugs), this route of administration remains a challenge. Oral chemotherapy may be an attractive option and especially appropriate for chronic treatment of cancer. However, this route of administration is particularly complicated for the administration of anticancer drugs ascribed to Class IV of the Biopharmaceutical Classification System. This group of compounds is characterized by low aqueous solubility and low intestinal permeability. This review focuses on the use of cyclodextrins alone or in combination with bioadhesive nanoparticles for oral delivery of drugs. The state-of-the-art technology and challenges in this area is also discussed.
Collapse
|
18
|
|
19
|
Nanotechnology: emerging tool for diagnostics and therapeutics. Appl Biochem Biotechnol 2011; 165:1178-87. [PMID: 21847590 DOI: 10.1007/s12010-011-9336-6] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2011] [Accepted: 08/02/2011] [Indexed: 01/04/2023]
Abstract
Nanotechnology is an emerging technology which is an amalgamation of different aspects of science and technology that includes disciplines such as electrical engineering, mechanical engineering, biology, physics, chemistry, and material science. It has potential in the fields of information and communication technology, biotechnology, and medicinal technology. It involves manipulating the dimensions of nanoparticles at an atomic scale to make use of its physical and chemical properties. All these properties are responsible for the wide application of nanoparticles in the field of human health care. Promising new technologies based on nanotechnology are being utilized to improve diverse aspects of medical treatments like diagnostics, imaging, and gene and drug delivery. This review summarizes the most promising nanomaterials and their application in human health.
Collapse
|
20
|
|
21
|
Lee KN, Ye Y, Carr JH, Karem K, D’Souza MJ. Formulation, pharmacokinetics and biodistribution of Ofloxacin-loaded albumin microparticles and nanoparticles. J Microencapsul 2011; 28:363-9. [DOI: 10.3109/02652048.2011.569766] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
22
|
Simultaneous in situ monitoring of acrylic acid polymerization reaction on N-carboxymethyl chitosan using multidetectors: Formation of a new bioadhesive and gastroprotective hybrid particle. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2011. [DOI: 10.1016/j.msec.2010.12.015] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
23
|
Elizondo E, Sala S, Imbuluzqueta E, González D, Blanco-Prieto MJ, Gamazo C, Ventosa N, Veciana J. High loading of gentamicin in bioadhesive PVM/MA nanostructured microparticles using compressed carbon-dioxide. Pharm Res 2010; 28:309-21. [PMID: 21125416 DOI: 10.1007/s11095-010-0248-x] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2010] [Accepted: 08/13/2010] [Indexed: 11/26/2022]
Abstract
PURPOSE To investigate, for the first time, the viability of compressed antisolvent methodologies for the preparation of drug-loaded particles of the biodegradable and bioadhesive polymer poly (methyl vinyl ether-co-maleic anhydride) (PVM/MA), utilizing gentamicin (Gm) as a model drug. METHODS Precipitation with a Compressed Antisolvent (PCA) method was used for the preparation of PVM/MA particles loaded with gentamicin. Before encapsulation, gentamicin was modified into a hydrophobic complex, GmAOT, by exchanging its sulphate ions with an anionic surfactant. GmAOT:PVM/MA composites were fully characterized in terms of size, morphology, composition, drug distribution, phase composition, in vitro activity and drug release. RESULTS Homogeneous nanostructured microparticles of PVM/MA loaded with high and uniformly distributed quantities of GmAOT were obtained by PCA. The drug loading factors could be tuned at will, improving up to ten times the loadings obtained by other precipitation techniques. Gentamicin retained its bioactivity after being processed, and, according to its release profiles, after an initial burst it experienced a sustained release over 30 days. CONCLUSIONS Compressed antisolvent methods are suitable technologies for the one-step preparation of highly loaded nanostructured PVM/MA matrices with promising application in the delivery of low bioavailable drugs.
Collapse
Affiliation(s)
- Elisa Elizondo
- Department of Molecular Nanoscience and Organic Materials, Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Bellaterra, 08193, Spain
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Elizondo E, Córdoba A, Sala S, Ventosa N, Veciana J. Preparation of biodegradable poly (methyl vinyl ether-co-maleic anhydride) nanostructured microparticles by precipitation with a compressed antisolvent. J Supercrit Fluids 2010. [DOI: 10.1016/j.supflu.2010.02.018] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
25
|
Ojer P, Salman H, Da Costa Martins R, Calvo J, López de Cerain A, Gamazo C, Lavandera J, Irache J. Spray-drying of poly(anhydride) nanoparticles for drug/antigen delivery. J Drug Deliv Sci Technol 2010. [DOI: 10.1016/s1773-2247(10)50059-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
26
|
Agüeros M, Ruiz-Gatón L, Vauthier C, Bouchemal K, Espuelas S, Ponchel G, Irache J. Combined hydroxypropyl-β-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel. Eur J Pharm Sci 2009; 38:405-13. [DOI: 10.1016/j.ejps.2009.09.010] [Citation(s) in RCA: 107] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2009] [Revised: 08/21/2009] [Accepted: 09/10/2009] [Indexed: 11/28/2022]
|
27
|
Bioadhesive properties and biodistribution of cyclodextrin–poly(anhydride) nanoparticles. Eur J Pharm Sci 2009; 37:231-40. [DOI: 10.1016/j.ejps.2009.02.010] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2008] [Revised: 02/10/2009] [Accepted: 02/15/2009] [Indexed: 11/17/2022]
|
28
|
Martini G, Ciani L. Electron spin resonance spectroscopy in drug delivery. Phys Chem Chem Phys 2009; 11:211-54. [DOI: 10.1039/b808263d] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
29
|
Wang G, Uludag H. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Expert Opin Drug Deliv 2008; 5:499-515. [PMID: 18491978 DOI: 10.1517/17425247.5.5.499] [Citation(s) in RCA: 72] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND Drug delivery systems with nm dimensions (nanoparticles [NPs]) are attracting increasing attention because they can sequester drugs in systemic circulation, prevent non-specific biodistribution, and target to specific tissues. OBJECTIVE We reviewed the recent literature pertinent to NP-based drug delivery, primarily emphasizing NPs fabricated from proteins. METHODS A summary of common NP fabrication techniques is provided along with the range of sizes and functional properties obtained. The NP properties critical for injectable drug delivery are reviewed, as well as the attempts to design 'tissue-specific' NPs. RESULTS/CONCLUSIONS It has been possible to design > 100 nm NPs from different biomaterials, and further understanding of in vivo stability and interactions with physiologic systems will lead to improved drug delivery systems.
Collapse
Affiliation(s)
- Guilin Wang
- Faculty of Engineering University of Alberta, Department of Chemical & Materials Engineering, #526 CME Building, Edmonton, Alberta, T6G2G6, Canada
| | | |
Collapse
|
30
|
Chiellini F, Piras AM, Errico C, Chiellini E. Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications. Nanomedicine (Lond) 2008; 3:367-93. [DOI: 10.2217/17435889.3.3.367] [Citation(s) in RCA: 77] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
This review provides an outline of the polymeric micro/nanostructured advanced systems that are suited for the controlled and targeted administration of, specifically, nonconventional drugs. The contribution of new trends in drug-delivery technology is focused on two major parts, dealing with brief surveys of: the biodegradable/bioerodible polymeric systems used in the formulation of micro/nanoparticles and techniques used in the preparation of micro/nanoparticles for their biomedical application in cancer treatment specifically, in inflammation pathologies, as oxygen carriers (blood substitutes) and in tissue-engineering practice. A small discussion of the future perspectives of the described systems is also given.
Collapse
Affiliation(s)
- Federica Chiellini
- Laboratory of Bioactive Polymeric Materials for Biomedical and Environmental Applications - UdR INSTM - Department of Chemistry & Industrial Chemistry, University of Pisa, Via Vecchia Livornese,1291, 56010, S. Piero a Grado (Pisa), Italy
| | - Anna Maria Piras
- Laboratory of Bioactive Polymeric Materials for Biomedical and Environmental Applications - UdR INSTM - Department of Chemistry & Industrial Chemistry, University of Pisa, Via Vecchia Livornese,1291, 56010, S. Piero a Grado (Pisa), Italy
| | - Cesare Errico
- Laboratory of Bioactive Polymeric Materials for Biomedical and Environmental Applications - UdR INSTM - Department of Chemistry & Industrial Chemistry, University of Pisa, Via Vecchia Livornese,1291, 56010, S. Piero a Grado (Pisa), Italy
| | - Emo Chiellini
- Laboratory of Bioactive Polymeric Materials for Biomedical and Environmental Applications - UdR INSTM - Department of Chemistry & Industrial Chemistry, University of Pisa, Via Vecchia Livornese,1291, 56010, S. Piero a Grado (Pisa), Italy
| |
Collapse
|
31
|
Pope-Harman A, Cheng MMC, Robertson F, Sakamoto J, Ferrari M. Biomedical nanotechnology for cancer. Med Clin North Am 2007; 91:899-927. [PMID: 17826110 DOI: 10.1016/j.mcna.2007.05.008] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Nanotechnology may hold the key to controlling many devastating diseases. In the fight against the pain, suffering, and death due to cancer, nanotechnology will allow earlier diagnosis and even prevention of malignancy at premalignant stages, in addition to providing multimodality treatment not possible with current conventional techniques. This review discusses nanotechnology already used in diagnostic and therapeutic applications for cancer. Also addressed are theoretic and evolving uses of nanotechnology, including multifunctional nanoparticles for imaging and therapy, nanochannel implants for controlled release of drugs, nanoscale devices for evaluation of proteomics and genomics, and diagnostic techniques that take advantage of physical changes in diseased tissue.
Collapse
Affiliation(s)
- Amy Pope-Harman
- Dorothy M. Davis Heart and Lung Research Institute, Department of Internal Medicine, The Ohio State University College of Medicine and Public Health, Columbus, OH 43210, USA.
| | | | | | | | | |
Collapse
|
32
|
Gómez S, Gamazo C, Roman BS, Ferrer M, Sanz ML, Irache JM. Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens. Vaccine 2007; 25:5263-71. [PMID: 17576025 DOI: 10.1016/j.vaccine.2007.05.020] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2007] [Revised: 04/19/2007] [Accepted: 05/13/2007] [Indexed: 11/23/2022]
Abstract
The aim of this study was to investigate the adjuvant properties of oral-administered Gantrez AN nanoparticles with ovalbumin (as allergen model) and, in some cases, lipopolysaccharide of Brucella ovis as immunomodulator. For this purpose, BALB/c mice were administered by oral gavage with OVA nanoparticles and both Th1 and Th2 markers (IgG2a and IgG1, respectively) were enhanced. On the other hand, these carriers administered by oral route were able to protect a model of sensitized mice to ovalbumin from anaphylactic shock. These results are highly suggestive for the valuable use of Gantrez nanoparticles in oral immunotherapy with allergens.
Collapse
Affiliation(s)
- Sara Gómez
- Adjuvant Unit, Department of Pharmaceutical Technology and Microbiology, University of Navarra, 31080 Pamplona, Spain
| | | | | | | | | | | |
Collapse
|
33
|
The present and future of nanotechnology in human health care. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2007; 3:20-31. [PMID: 17379166 DOI: 10.1016/j.nano.2006.11.008] [Citation(s) in RCA: 361] [Impact Index Per Article: 21.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/03/2006] [Revised: 10/04/2006] [Accepted: 11/21/2006] [Indexed: 12/13/2022]
Abstract
Nanotechnology is a multidisciplinary field that covers a vast and diverse array of devices derived from engineering, physics, chemistry, and biology. The burgeoning new field of nanotechnology, opened up by rapid advances in science and technology, creates myriad new opportunities for advancing medical science and disease treatment in human health care. Applications of nanotechnology to medicine and physiology imply materials and devices designed to interact with the body at subcellular (i.e., molecular) scales with a high degree of specificity. This can be potentially translated into targeted cellular and tissue-specific clinical applications designed to achieve maximal therapeutic efficacy with minimal side effects. In this review the chief scientific and technical aspects of nanotechnology are introduced, and some of its potential clinical applications are discussed.
Collapse
|
34
|
Sonaje K, Italia JL, Sharma G, Bhardwaj V, Tikoo K, Kumar MNVR. Development of Biodegradable Nanoparticles for Oral Delivery of Ellagic Acid and Evaluation of Their Antioxidant Efficacy Against Cyclosporine A-Induced Nephrotoxicity in Rats. Pharm Res 2007; 24:899-908. [PMID: 17377747 DOI: 10.1007/s11095-006-9207-y] [Citation(s) in RCA: 107] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2006] [Accepted: 12/04/2006] [Indexed: 12/11/2022]
Abstract
PURPOSE Ellagic acid (EA), a dietary antioxidant associated with poor biopharmaceutical properties, was encapsulated into poly(lactide-co-glycolide) (PLGA) and polycaprolactone (PCL) nanoparticles to improve oral bioavailability. MATERIALS AND METHODS EA-loaded nanoparticles were prepared following emulsion-diffusion-evaporation method employing didodecyldimethyl ammonium bromide (DMAB) and polyvinyl alcohol (PVA) as stabilizers. In vitro release was investigated in phosphate buffer (pH 7.4). The in situ permeation studies were performed in rats. The antioxidant potential of the DMAB-stabilized nanoparticulate formulations was evaluated against cyclosporine A (CyA)-induced nephrotoxicity in rats. RESULTS EA-loaded PLGA and PCL nanoparticles have been successfully prepared employing PEG 400 as co-solvent to solubilize EA. The stabilizers influenced the particle size and encapsulation efficiency. DMAB when used as stabilizer to particles of approximately 120 nm and approximately 50% encapsulation, whereas PVA led to approximately 290 nm and approximately 60% encapsulation at 5% initial loading (w/w of polymer). The in vitro release of EA from the nanoparticles followed Higuchi's square root pattern and was faster with PVA-stabilized particles in comparison to those stabilized with DMAB. From the in situ permeation studies in rats, it was evident that intestinal uptake of EA as DMAB-stabilized nanoparticles was significantly higher as compared to the sodium carboxymethyl cellulose suspension and the PVA-stabilized particles. EA and EA nanoparticles were able to prevent the CyA-induced nephrotoxicity in rats as evident by biochemical parameters as well as kidney histopathology. CONCLUSION The present study demonstrates the potential of EA nanoparticulate formulations in the prevention of CyA-induced nephrotoxicity at three times lower dose suggesting improved oral bioavailability of EA.
Collapse
Affiliation(s)
- K Sonaje
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Mohali, Punjab, 160062, India
| | | | | | | | | | | |
Collapse
|
35
|
Wongmekiat A, Tozuka Y, Moribe K, Oguchi T, Yamamoto K. Preparation of Drug Nanoparticles by Co-grinding with Cyclodextrin: Formation Mechanism and Factors Affecting Nanoparticle Formation. Chem Pharm Bull (Tokyo) 2007; 55:359-63. [PMID: 17329871 DOI: 10.1248/cpb.55.359] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The aim of this study was to investigate the factors affecting the formation of pranlukast nanoparticle prepared by co-grinding with beta-cyclodextrin (beta-CD) and to elucidate the mechanism of nanoparticle formation. The effects of grinding time, moisture content and CD content on the nanoparticle formation were evaluated by means of UV quantitative determination and particle size analysis. High-resolution scanning electron microscopy (HRSEM) was employed to observe drug nanoparticles in the ground mixture. Nanoparticle recovery was higher than 95% for 2 : 1 molecular mixtures of beta-CD : pranlukast which had been ground for 10 min with moisture levels between 10 and 15%. While that of the 1 : 2 ground mixture prepared at 8% moisture level was only 57%. Nanoparticle recovery from beta-CD : pranlukast 2 : 1 mixture ground for 1 min was 2.5%, while that of the 10 min ground mixture was as high as 95%. HRSEM demonstrated that primary drug nanoparticles having a particle size around 50 nm were observed in the ground mixture. The grinding time, the moisture content, and the CD content had significant influences on the formation of drug nanoparticles. The CD matrix may form and stabilize primary particles by its interaction with the particle surface through water molecules. Primary nanoparticles existed in the ground mixture as 50 nm drug nanocrystallites.
Collapse
|
36
|
Salman HH, Gamazo C, Campanero MA, Irache JM. Salmonella-like bioadhesive nanoparticles. J Control Release 2006; 106:1-13. [PMID: 15970347 DOI: 10.1016/j.jconrel.2005.03.033] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2004] [Revised: 02/21/2005] [Accepted: 03/02/2005] [Indexed: 02/08/2023]
Abstract
The aim of this work was to evaluate the bioadhesive potential of a polymeric vector obtained by the association between Gantrez AN nanoparticles and flagella-enriched Salmonella enteritidis extract. Fluorescently labelled nanoparticles (SE-NP) were prepared, after incubation between the polymer and the extract, by a solvent displacement method and cross-linkage with 1,3-diaminopropane. SE-NP displayed a size close to 280 nm and the amount of associated bacterial extract was 18 mug/mg nanoparticle. Flagellin represents more than 80% of the total proteins associated with SE-NP, which was identified by SDS-PAGE and confirmed by Western blotting. Concerning the bioadhesive properties, SE-NP shows an important tropism for the ileum. In fact, about 50% of the given dose of SE-NP was found in this gut region for at least 3 h. Interestingly, the bioadhesive ability of SE-NP correlated well with the described colonisation profile for Salmonella enteritidis. This fact was corroborated by competitive tissue distribution studies. Thus, when SE-NP and Salmonella cells were administered together by the oral route, both the bacteria and the nanoparticles displayed a similar distribution within the intestinal mucosa. However, the ability of SE-NP to be taken up by Peyer's patches appeared to be negatively affected by the presence of the bacteria. Similarly, when SE-NP was administered 30 min before cells, SE-NP were found broadly distributed in Peyer's patches, whereas the bacteria were neither able to adhere to nor penetrate this lymphoid tissue. In summary, SE-NP demonstrated their Salmonella-like gut colonization, which can be a useful vector for oral targeting strategies.
Collapse
Affiliation(s)
- Hesham H Salman
- Centro Galénico, Facultad de Farmacia, University of Navarra, Apartado. 177, 31080 Pamplona, Spain
| | | | | | | |
Collapse
|
37
|
Abstract
Development of new delivery systems that deliver the potential drug specifically to the target site in order to meet the therapeutic needs of the patients at the required time and level remains the key challenge in the field of pharmaceutical biotechnology. Developments in this context to achieve desired goal has led to the evolution of the multidisciplinary field nanobiotechnology which involves the combination of two most promising technologies of 21st century--biotechnology and nanotechnology. Nanobiotechnology encompasses a wide array of different techniques to improve the delivery of biotech drugs, and nanoparticles offer the most suitable form whose properties can be tailored by chemical methods. This review highlights the different types of nanoparticulate delivery systems employed for biotech drugs in the field of molecular medicine with a short overlook at its applications and the probable associated drawbacks.
Collapse
Affiliation(s)
- Manju Rawat
- Institute of Pharmacy, Pt Ravishankar Shukla University, Raipur, India
| | | | | | | |
Collapse
|
38
|
Kidane A, Bhatt PP. Recent advances in small molecule drug delivery. Curr Opin Chem Biol 2005; 9:347-51. [PMID: 16006179 DOI: 10.1016/j.cbpa.2005.06.006] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2005] [Accepted: 06/22/2005] [Indexed: 11/29/2022]
Abstract
The majority of new drugs, and new drug products, being developed and marketed by the pharmaceutical industry are small molecules. Oral administration remains the most common route of delivering such drugs, typically in the form of immediate-release tablets or capsules. While the immediate-release dosage forms dominate the market today, more specialized and rationalized products incorporating the concepts of drug delivery are being developed to overcome the physicochemical, physiological and pharmacological challenges inherent with the drugs, and to improve the treatment regimens for the patients. Today, these specialized concepts are increasingly being applied to first-generation products and not just products intended for the life cycle management of the franchise.
Collapse
Affiliation(s)
- Argaw Kidane
- Advanced Drug Delivery, Shire Laboratories, Inc., Rockville, Maryland, USA
| | | |
Collapse
|
39
|
Abstract
Oral delivery of drugs to the small intestine is an important topic in the research and development of more effective oral dose forms. This review highlights several important developments in this area. An overriding theme in drug delivery to the small intestine is how to increase the efficiency (ie, how to increase bioavailability) of absorption. The role of P-glycoprotein and intestinal transporters is discussed in this regard. These systems are normally studied under defined in vitro conditions; recent data suggest that this approach, though useful, may not fully represent the in vivo situation. Recent advances and issues in the characterization and prediction of drug absorption from the small intestine are reviewed. These efforts, if successful, will shorten development timelines by eliminating compounds with poor absorption characteristics early in the process. Nanoparticulate delivery systems and those prepared by microfabrication technology are being used to improve bioavailability of poorly absorbed drugs. A relatively new technique (electroporation) has been proposed to enhance oral delivery of macromolecules, still an unrealized objective in drug delivery.
Collapse
Affiliation(s)
- David R Friend
- MicroDose Technologies, Inc., 4262 US Route 1, Monmouth Junction, NJ 08852, USA.
| |
Collapse
|
40
|
Irache JM, Huici M, Konecny M, Espuelas S, Campanero MA, Arbos P. Bioadhesive properties of Gantrez nanoparticles. Molecules 2005; 10:126-45. [PMID: 18007282 PMCID: PMC6147552 DOI: 10.3390/10010126] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2004] [Accepted: 06/30/2004] [Indexed: 11/18/2022] Open
Abstract
Bioadhesive nanoparticles have been proposed as carriers for the oral delivery of poorly available drugs and facilitate the use of this route. This work summarises some experiments describing the bioadhesive potential of Gantrez nanoparticles fluorescently labeled with rhodamine B isothiocyanate. The adhesive potential of Gantrez was found to be stronger when folded as nanoparticles than in the solubilised form. Conventional nanoparticles displayed a tropism for the upper areas of the gastrointestinal tract, with a maximum of adhesion 30 min post-administration and a decrease in the adhered fraction along the time depending on the given dose. The cross-linkage of nanoparticles with increasing amounts of 1,3-diaminopropane stabilised the resulting carriers and prolonged their half-life in an aqueous environment; although, the adhesive capacity of nanoparticles, the intensity and the relative duration of the adhesive interactions within the gut as a function of the cross-linking degree. Finally, nanoparticles were coated with either gelatin or albumin. In the first case, the presence of gelatin dramatically decreased the initial capacity of these carriers to interact with the gut mucosa and the intensity of these phenomenons. In the latter, bovine serum albumin coated nanoparticles (BSA-NP) showed an important tropism for the stomach mucosa without further significant distribution to other parts of the gut mucosa.
Collapse
Affiliation(s)
- Juan M Irache
- Centro Galénico, Universidad de Navarra, 31080 - Pamplona (Spain).
| | | | | | | | | | | |
Collapse
|